You are here: Industry Insights > Brand Story > Shenzhen BONA Pharma Technology Co.,Ltd- Exhibitor Webinar

Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!

Note: You can unsubscribe from the alerts at any time.

Advertising

New Products

SG-DJ10 Capsule and Tablet Sample Checkweigher

NADP+

NMN

Ceritinib (LDK378) CAS:1032900-25-6

SG-JN10 0.1mg Tablet Capsule Check Weigher

β-Nicotinamide Adenine Dinucleotide (NAD+)

Shenzhen BONA Pharma Technology Co.,Ltd- Exhibitor Webinar

August 10, 2020

Tag: Exhibitor Webinar , VEC , CPHI China

Favorites

Company Name: Shenzhen BONA Pharma Technology Co.,Ltd

Company Profile ：Since 1995, Bona has been manufacturing metered spray pumps and medicinal bottles. To ensure consistent quality, we strictly follow an ISO15378:2017 certified management principle throughout the entire manufacturing process. All the resins we used are approved by FDA and EU 10/2011. Now our products are produced, assembled and packed in class 100,000 or class 10,000 clean room. Customers include Novartis, Wyeth and Merck etc.

Title：Drugs Delivery System

Speaker ：Elena Lu, Allen Zhang

For more information, click here to view my store.

Previous:Licensing agreement deals decline in rare diseases space: GlobalData

Next:Novateur Ventures explores new strategy to reduce hyperinflammatory response caused by COVID-19

What companies are developing CNS drugs in China?

ChatGTP/PharmaSourcesNovember 08, 2023

Several pharmaceutical and biotechnology companies in China are actively involved in the research and development of Central Nervous System (CNS) drugs.

Shanghai Dayou Chromatagraphy Technology Service Co., Ltd.——Professional chromatographic filler supplier for industrial scale production

PharmaSourcesMay 15, 2023

International Perspective, Cutting-edge Technology Learning - Entering into HongKe(虹科) Technology Co., Ltd.

PharmaSources.comMay 27, 2022

Shenzhen BONA Pharma Technology Co.,Ltd- Exhibitor Webinar | Pharmasources.com

Established For Non-Sterile API and Pharmaceutical Intermediates, Ningxia Taiyicin Biotech Co., LTD.

PharmaSources.comDecember 30, 2021

Ningxia Taiyicin founded in 2010, covering about 221.73 hectares of construction area with registered capital RMB 625 million, is mainly established for Non-sterile API and pharmaceutical intermediates.

Shenzhen BONA Pharma Technology Co.,Ltd- Exhibitor Webinar

Related News

What companies are developing CNS drugs in China?

Shanghai Dayou Chromatagraphy Technology Service Co., Ltd.——Professional chromatographic filler supplier for industrial scale production

International Perspective, Cutting-edge Technology Learning - Entering into HongKe(虹科) Technology Co., Ltd.

Established For Non-Sterile API and Pharmaceutical Intermediates, Ningxia Taiyicin Biotech Co., LTD.

You may like
More>>

Shenzhen BONA Pharma Technology Co.,Ltd- Exhibitor Webinar

Related News

What companies are developing CNS drugs in China?

Shanghai Dayou Chromatagraphy Technology Service Co., Ltd.——Professional chromatographic filler supplier for industrial scale production

International Perspective, Cutting-edge Technology Learning - Entering into HongKe(虹科) Technology Co., Ltd.

Established For Non-Sterile API and Pharmaceutical Intermediates, Ningxia Taiyicin Biotech Co., LTD.

You may likeMore>>

You may like
More>>